Status: current, Defined. Date: 30-Apr 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4357491000168111 | Trajentamet 2.5 mg/500 mg (linagliptin 2.5 mg + metformin hydrochloride 500 mg) tablet, 14 tablets, bottle (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4357501000168116 | Trajentamet 2.5 mg/500 mg tablet, 14, bottle | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Trajentamet 2.5 mg/500 mg tablet, 14, bottle | Is a | Trajentamet 2.5 mg/500 mg tablet, 14 | true | Inferred relationship | Some | ||
| Trajentamet 2.5 mg/500 mg tablet, 14, bottle | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Trajentamet 2.5 mg/500 mg tablet, 14, bottle | has container type | bottle | true | Inferred relationship | Some | ||
| Trajentamet 2.5 mg/500 mg tablet, 14, bottle | has TP | Trajentamet 2.5 mg/500 mg | true | Inferred relationship | Some | ||
| Trajentamet 2.5 mg/500 mg tablet, 14, bottle | has TPUU | Trajentamet 2.5 mg/500 mg tablet | true | Inferred relationship | Some | 449593096 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Description inactivation indicator reference set
Containered trade product pack reference set
FHIR